commercialize oritavancin

Related by string. * Commercialize . Commercializes . commercializes : commercializes innovative therapeutics . commercializes innovative biopharmaceuticals . successfully commercialize REOLYSIN . commercializes differentiated products . commercialize microRNA therapeutics . ViroPharma commercializes Vancocin / Oritavancin : oritavancin semi . oritavancin * *

Related by context. Frequent words. (Click for all words.) 66 Marketing Authorization Application MAA 63 Marketing Authorization Application 63 FDA approvable letter 62 orphan designation 62 Orphan Drug status 61 submitted Marketing Authorization 61 Orphan Drug designation 61 submitted Biologics License 60 Pirfenidone 60 Orphan Medicinal Product 60 Pivotal Phase III 60 Positive Opinion 59 orphan medicinal product 59 FDA Accepts 59 Marketing Authorization 58 application sNDA 58 Orphan Drug Status 58 sNDA 58 ZALBIN 58 diabetic neuropathic pain 57 Actelion Ltd 57 supplemental Biologics License Application 57 Biologics License Application BLA 57 Orphan Drug Designation 57 lymphoma CTCL 57 Complete Response letter 57 Torisel 57 Phase III Clinical Trial 56 REPLAGAL 56 Complete Response 56 aztreonam lysine 56 R sorafenib tablets 56 REVLIMID R 56 Zalbin 56 undergoing coronary angioplasty 56 angioedema attacks 56 USFDA approval 56 painful diabetic neuropathy 56 Completes Enrollment 56 Amrubicin 55 Promacta 55 Vitaros 55 Clevudine 55 sBLA 55 Act PDUFA date 55 FIRAZYR 55 Presents Positive 55 eltrombopag 55 silodosin 55 alvimopan 55 Omigard 54 Drug Application 54 methylnaltrexone 54 Fast Track designation 54 diabetic peripheral neuropathic pain 54 C1 esterase inhibitor 54 chronic angina 54 Biologics License Application 54 Medicinal Products EMEA 54 Mutual Recognition Procedure 54 Jevtana 54 REMICADE ® 54 Investigational Device Exemption 54 Nexavar ® 54 Clinical Trial Application 54 SCHWARZ PHARMA 54 REVLIMID lenalidomide 54 Abstral 54 Pegintron 53 Rhucin 53 Humanitarian Device Exemption 53 Phase III Trial 53 Rhucin ® 53 European Medicines Evaluation 53 Hycamtin 53 Relistor 53 Icatibant 53 Loramyc ® 53 Fast Track Designation 53 pediatric exclusivity 52 QNEXA 52 REVLIMID ® 52 PROMACTA 52 Arixtra 52 CHMP opinion 52 Complete Response Letter 52 TORISEL 52 bazedoxifene 52 Vandetanib 52 vandetanib 52 hepatitis C HCV 52 Veronate 52 Initiates Phase 52 Panzem R 52 fidaxomicin 52 Herceptin trastuzumab 52 Cimzia ® 52 Scientific Advice 52 Oral Solution 52 Irinotecan 51 Horizant

Back to home page